Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Omega-3 fatty acids for bipolar disorder
Your Article Summary
Efficacy of behavioural interventions in managing atypical antipsychotic weight gain
Obesity Reviews, 07/02/09
Gabriele JM et al. - Atypical antipsychotic treatment is associated with weight gain and increased metabolic risk. The information will be useful in determining what types of interventions are both effective and practical for delivery in health care or community mental health settings.
Related Articles
Use Of Antipsychotic Medications By Children And Adolescents Associated With Significant Weight Gain
Internet Source, 10/29/09
Relevance Score: 81%
Antipsychotics cause rapid weight gain in youth
Reuters, 10/28/09
Relevance Score: 80%
Metabolic and Cardiac Side Effects of Second-generation Antipsychotics: What Every Clinician Should Know
Journal of Pharmacy Practice, 11/05/09
Relevance Score: 79%
Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents
JAMA, 10/29/09
Relevance Score: 79%
Aripiprazole versus other atypical antipsychotics for schizophrenia
Cochrane Reviews, 10/21/09
Relevance Score: 78%
Today in Neuro/Psych Pharmacol...keeping you current
Receive free subspecialty "5-minute updates" via email
Zuclopenthixol-induced neuroleptic malignant syndrome presenting as fever of unknown origin, hyperglycaemia and acute myocardial infarction in a 60-year-old man
World Journal of Biological Psychiatry, 12/19/09
Quetiapine-associated dysphagia
World Journal of Biological Psychiatry, 12/19/09
A case with occurring adverse effects when cross-over titration from fluvoxamine to paroxetine associated with increasing the plasma fluvoxamine level in major depressive disorder
World Journal of Biological Psychiatry, 12/19/09
Today in Neuro/Psych Pharmacol...keeping you current
Receive free subspecialty "5-minute updates" via email
Zuclopenthixol-induced neuroleptic malignant syndrome presenting as fever of unknown origin, hyperglycaemia and acute myocardial infarction in a 60-year-old man
World Journal of Biological Psychiatry, 12/19/09
Quetiapine-associated dysphagia
World Journal of Biological Psychiatry, 12/19/09
A case with occurring adverse effects when cross-over titration from fluvoxamine to paroxetine associated with increasing the plasma fluvoxamine level in major depressive disorder
World Journal of Biological Psychiatry, 12/19/09
Today in Schizophrenia/Psychosis...keeping you current
Receive free subspecialty "5-minute updates" via email
Magnetoencephalographic Characteristics of Psychosis in Temporal Lobe Epilepsy
Journal of Neuropsychiatry and Clinical Neurosciences, 12/19/09
Zuclopenthixol-induced neuroleptic malignant syndrome presenting as fever of unknown origin, hyperglycaemia and acute myocardial infarction in a 60-year-old man
World Journal of Biological Psychiatry, 12/19/09
Quetiapine-associated dysphagia
World Journal of Biological Psychiatry, 12/19/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


